vs
安捷伦科技（A）与Aveanna Healthcare Holdings, Inc.（AVAH）财务数据对比。点击上方公司名可切换其他公司
安捷伦科技的季度营收约是Aveanna Healthcare Holdings, Inc.的2.9倍（$1.8B vs $621.9M）。安捷伦科技净利率更高（17.0% vs 2.3%，领先14.7%）。Aveanna Healthcare Holdings, Inc.同比增速更快（22.2% vs 7.0%）。过去两年Aveanna Healthcare Holdings, Inc.的营收复合增速更高（14.0% vs 6.9%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
Aveanna Healthcare Holdings, Inc.是美国领先的家庭及社区医疗服务提供商，核心业务覆盖儿科家庭护理、成人个人照护、临终关怀、输液治疗等领域，通过覆盖全美的本地护理中心网络为各地患者提供服务，服务对象涵盖公共及私人付费群体。
A vs AVAH — 直观对比
营收规模更大
A
是对方的2.9倍
$621.9M
营收增速更快
AVAH
高出15.2%
7.0%
净利率更高
A
高出14.7%
2.3%
两年增速更快
AVAH
近两年复合增速
6.9%
损益表 — Q1 2026 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $621.9M |
| 净利润 | $305.0M | $14.1M |
| 毛利率 | 52.6% | 32.6% |
| 营业利润率 | 19.6% | 8.6% |
| 净利率 | 17.0% | 2.3% |
| 营收同比 | 7.0% | 22.2% |
| 净利润同比 | -4.1% | 132.8% |
| 每股收益（稀释后） | $1.07 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AAVAH
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.7B | $621.9M | ||
| Q2 25 | $1.7B | $589.6M | ||
| Q1 25 | $1.7B | $559.2M | ||
| Q4 24 | $1.7B | $519.9M | ||
| Q3 24 | $1.6B | $509.0M | ||
| Q2 24 | $1.6B | $505.0M |
净利润AAVAH
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | — | ||
| Q3 25 | $336.0M | $14.1M | ||
| Q2 25 | $215.0M | $27.0M | ||
| Q1 25 | $318.0M | $5.2M | ||
| Q4 24 | $351.0M | $29.2M | ||
| Q3 24 | $282.0M | $-42.8M | ||
| Q2 24 | $308.0M | $13.9M |
毛利率AAVAH
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | 32.6% | ||
| Q2 25 | 51.9% | 35.8% | ||
| Q1 25 | 53.5% | 32.8% | ||
| Q4 24 | 53.9% | 33.0% | ||
| Q3 24 | 54.2% | 31.4% | ||
| Q2 24 | 54.4% | 31.3% |
营业利润率AAVAH
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 20.7% | 8.6% | ||
| Q2 25 | 18.0% | 13.6% | ||
| Q1 25 | 22.4% | 9.3% | ||
| Q4 24 | 24.0% | 8.8% | ||
| Q3 24 | 21.1% | 6.7% | ||
| Q2 24 | 23.1% | 7.4% |
净利率AAVAH
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | — | ||
| Q3 25 | 19.3% | 2.3% | ||
| Q2 25 | 12.9% | 4.6% | ||
| Q1 25 | 18.9% | 0.9% | ||
| Q4 24 | 20.6% | 5.6% | ||
| Q3 24 | 17.9% | -8.4% | ||
| Q2 24 | 19.6% | 2.8% |
每股收益（稀释后）AAVAH
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | — | ||
| Q3 25 | $1.18 | $0.06 | ||
| Q2 25 | $0.75 | $0.13 | ||
| Q1 25 | $1.11 | $0.03 | ||
| Q4 24 | $1.23 | $0.15 | ||
| Q3 24 | $0.97 | $-0.22 | ||
| Q2 24 | $1.05 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $145.9M |
| 总债务越低越好 | $3.0B | $1.3B |
| 股东权益账面价值 | $6.9B | $9.2M |
| 总资产 | $12.8B | $1.8B |
| 负债/权益比越低杠杆越低 | 0.44× | 141.83× |
8季度趋势，按日历期对齐
现金及短期投资AAVAH
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.5B | $145.9M | ||
| Q2 25 | $1.5B | $100.7M | ||
| Q1 25 | $1.5B | $71.5M | ||
| Q4 24 | $1.3B | $84.3M | ||
| Q3 24 | $1.8B | $78.5M | ||
| Q2 24 | $1.7B | $47.7M |
总债务AAVAH
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.4B | $1.3B | ||
| Q2 25 | $3.3B | $1.3B | ||
| Q1 25 | $3.3B | $1.3B | ||
| Q4 24 | $3.3B | $1.3B | ||
| Q3 24 | $2.1B | $1.3B | ||
| Q2 24 | $2.1B | $1.3B |
股东权益AAVAH
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | — | ||
| Q3 25 | $6.4B | $9.2M | ||
| Q2 25 | $6.1B | $-12.0M | ||
| Q1 25 | $6.0B | $-100.1M | ||
| Q4 24 | $5.9B | $-123.6M | ||
| Q3 24 | $5.9B | $-156.4M | ||
| Q2 24 | $6.2B | $-119.0M |
总资产AAVAH
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | — | ||
| Q3 25 | $12.2B | $1.8B | ||
| Q2 25 | $12.2B | $1.8B | ||
| Q1 25 | $11.9B | $1.7B | ||
| Q4 24 | $11.8B | $1.7B | ||
| Q3 24 | $11.0B | $1.6B | ||
| Q2 24 | $10.9B | $1.7B |
负债/权益比AAVAH
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.53× | 141.83× | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | $33.2M |
| 自由现金流经营现金流 - 资本支出 | $175.0M | — |
| 自由现金流率自由现金流/营收 | 9.7% | — |
| 资本支出强度资本支出/营收 | 5.2% | — |
| 现金转化率经营现金流/净利润 | 0.88× | 2.36× |
| 过去12个月自由现金流最近4个季度 | $993.0M | — |
8季度趋势，按日历期对齐
经营现金流AAVAH
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | — | ||
| Q3 25 | $362.0M | $33.2M | ||
| Q2 25 | $221.0M | $51.6M | ||
| Q1 25 | $431.0M | $-8.6M | ||
| Q4 24 | $481.0M | $13.4M | ||
| Q3 24 | $452.0M | $29.4M | ||
| Q2 24 | $333.0M | $1.8M |
自由现金流AAVAH
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | — | ||
| Q3 25 | $259.0M | — | ||
| Q2 25 | $107.0M | — | ||
| Q1 25 | $334.0M | — | ||
| Q4 24 | $388.0M | — | ||
| Q3 24 | $360.0M | — | ||
| Q2 24 | $230.0M | — |
自由现金流率AAVAH
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 19.9% | — | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 14.6% | — |
资本支出强度AAVAH
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 6.5% | — |
现金转化率AAVAH
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | — | ||
| Q3 25 | 1.08× | 2.36× | ||
| Q2 25 | 1.03× | 1.91× | ||
| Q1 25 | 1.36× | -1.66× | ||
| Q4 24 | 1.37× | 0.46× | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.08× | 0.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |
